Canada Markets closed

Tryp Therapeutics Inc. (TRYPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2999+0.0208 (+7.45%)
At close: 3:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2791
Open0.3039
BidN/A x N/A
AskN/A x N/A
Day's Range0.2790 - 0.3050
52 Week Range0.2701 - 1.0400
Volume20,738
Avg. Volume96,357
Market Cap19.889M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Tryp Therapeutics to Present at 15th Annual Pain Therapeutics Summit

    San Diego, California--(Newsfile Corp. - October 26, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the Company will present at the 15th Annual Pain Therapeutics Summit on November 1, 2021 at 12:15 p.m. EDT.The virtual conference will take place on November 1-3, 2021. Greg McKee, Chairman and CEO, will provide an overview of ...

  • Newsfile

    Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders

    San Diego, California--(Newsfile Corp. - October 20, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the U.S. Food and Drug Administration ("FDA") has placed a clinical hold on the Company's Phase 2a study for eating disorders that includes binge eating disorder and hypothalamic obesity. The notification from the FDA did not provide

  • CNW Group

    KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

    Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.